| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.32 | 0.004 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |